ZELDOX

This brand name is authorized in Australia, Austria, Canada, Croatia, Estonia, Finland, Germany, Hong Kong SAR China, Lithuania, Spain, Tunisia, Turkey.

Active ingredients

The drug ZELDOX contains one active pharmaceutical ingredient (API):

1	Ziprasidone hydrochloride monohydrate UNII 216X081ORU - ZIPRASIDONE HYDROCHLORIDE
	Ziprasidone has been shown to be an antagonist at both serotonin type 2A (5HT2A) and dopamine type 2 (D2) receptors. It is proposed that the therapeutic activity is mediated, in part, through this combination of antagonist activities. Ziprasidone is also a potent antagonist at 5HT2C and 5HT1D receptors, a potent agonist at the 5HT1A receptor and inhibits neuronal reuptake of norepinephrine and serotonin.
	Read more about Ziprasidone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZELDOX Capsule	MPI, CA: SPM	Health Products and Food Branch (CA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AE04	Ziprasidone	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AE Indole derivatives
Discover more medicines within N05AE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	9070J, 9071K, 9072L, 9073M
CA	Health Products and Food Branch	02298597, 02298600, 02298619, 02298627
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01074911, 01890473, 01897647, 01897653, 01897676, 02583023, 02583069, 02583098, 02583106, 02583129, 02727769, 02727781, 02752589, 03390556, 04052241, 04193496, 04563243, 05396385, 05396416, 05450699, 06057099, 06339455, 06590623, 06925733, 06927755, 16201143, 16201166, 16682734
EE	Ravimiamet	1119215, 1119271, 1119316, 1811203, 1816613
ES	Centro de información online de medicamentos de la AEMPS	64851, 64852, 64853, 64854, 64855
FI	Lääkealan turvallisuus- ja kehittämiskeskus	003872, 083246, 083535, 119792, 498980
HK	Department of Health Drug Office	48922, 48923, 48924, 48925
HR	Agencija za lijekove i medicinske proizvode	HR-H-174758493, HR-H-772516622, HR-H-834050107
LT	Valstybinė vaistų kontrolės tarnyba	1004162, 1004163, 1004164, 1010551, 1010552, 1010553, 1010554, 1010555, 1010556, 1010557, 1010558, 1010559, 1020328, 1020329, 1056454, 1056455, 1056456, 1056457, 1087366, 1087367
TN	Direction de la Pharmacie et du Médicament	3263041, 3263042
TR	İlaç ve Tıbbi Cihaz Kurumu	8699532151797, 8699532151810, 8699532151834, 8699532151858